GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regnum Corp (OTCPK:RGMP) » Definitions » Cash Paid for Insurance Activities
中文

Regnum (Regnum) Cash Paid for Insurance Activities


View and export this data going back to 2019. Start your Free Trial

Cash Paid for Insurance Activities only applicable to companies reporting Cash Flow from Operations in direct method.


Regnum (Regnum) Business Description

Industry
Traded in Other Exchanges
N/A
Address
600 Third Avenue, 19th Floor, New York, NY, USA, 10016
Regnum Corp is focused on developing and commercializing therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a CCR5 antagonist to treat multi-drug resistant HIV infection.